Zilretta
Zilretta is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 25.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
25.0%
1 of 4 finished
75.0%
3 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip
ZILRETTA in Subjects With Shoulder Osteoarthritis
Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury
Trial Comparing Three Single Dose Injections for Knee Osteoarthritis
Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis
Clinical Trials (6)
A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip
ZILRETTA in Subjects With Shoulder Osteoarthritis
Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury
Trial Comparing Three Single Dose Injections for Knee Osteoarthritis
Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis
The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OA
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6